LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Stocks making the biggest moves premarket: GitLab, CVS Health, Take-Two Interactive & more

Garry Wills by Garry Wills
December 5, 2023
in Business Finance
Stocks making the biggest moves premarket: GitLab, CVS Health, Take-Two Interactive & more
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

[ad_1]

Check out the companies making headlines before the bell. GitLab — GitLab shares popped more than 14% after the maker of developer tool software posted stronger-than-expected fiscal first-quarter results and shared upbeat guidance. The company posted its first adjusted operating profit and said revenue grew 32% year over year. For the fourth quarter, GitLab anticipated adjusted earnings of 8 cents to 9 cents per share on $157 million to $158 million in revenue. CVS Health —The pharmacy stock climbed 3% in premarket trading after the company provided higher-than-expected revenue guidance for 2024. CVS now expects revenue of at least $366 billion, while analysts polled by FactSet forecast $344.5 billion. The company also plans to raise its quarterly dividend by 9.9% beginning in the February quarter. Take-Two Interactive — The video game publisher’s stock fell more than 4% before the bell. Subsidiary Rockstar Games released the trailer for the new iteration of its Grand Theft Auto game, which is slated for 2025, earlier than expected following a leak on social media platform X. Nokia , Ericsson — U.S.-listed shares Nokia dropped 6.3% after losing a $14 billion deal to build a new telecom network for AT & T to Ericsson. Nokia, based in Finland, will see its existing equipment replaced in several places. U.S.-listed shares of Ericsson, based in Sweden, popped 2.7%. Johnson & Johnson —Johnson & Johnson’s stock rose nearly 1% after the pharmaceutical company offered 2024 guidance and said it expects operational sales growth to range between 5% and 6% next year. That topped a FactSet estimate of 3.6%. The drugmaker also said it has more than 10 assets with peak sales potential exceeding $5 billion. UBS — UBS shares slipped nearly 2% after Bank of America downgraded the Swiss bank to neutral, citing higher costs as it integrates Credit Suisse post-acquisition. Albemarle — The lithium company about 2% after Piper Sandler downgraded shares to underweight and trimmed its price target, citing global price declines. AutoZone — Shares dipped 1.5% after AutoZone posted mixed fiscal first-quarter results . The auto parts retailer posted earnings of $32.55 per share, topping the FactSet consensus estimate of $31.57 per share. The revenue of $4.19 billion came in line with expectations. J.M. Smucker — Shares of the snack food company rose 3% in premarket trading after J.M. Smucker topped earnings expectations for its fiscal second quarter. Net sales rose year over year when excluding the pet food brands J.M. Smucker sold off in April. Adecoagro — The Latin American agriculture stock rose 2.3%. Bank of America upgraded shares of Adecoagro to buy from neutral, saying that better sugar cane yields could fuel earnings growth in 2024. — CNBC’s Jesse Pound, Brian Evans, Sarah Min and Michelle Fox contributed reporting

[ad_2]

Source link

You might also like

China exports growth in March misses estimates, imports surge most in over four years

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

Share30Tweet19
Previous Post

Italy and South Korea central banks agree on CBDC cooperation

Next Post

Lucid Motors (LCID) updates its 2024 model year Airs, including lower prices and a RWD Pure

Garry Wills

Garry Wills

Recommended For You

China exports growth in March misses estimates, imports surge most in over four years
Business Finance

China exports growth in March misses estimates, imports surge most in over four years

April 14, 2026
Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more
Business Finance

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

April 13, 2026
Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects
Business Finance

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

April 13, 2026
Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions
Business Finance

Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions

April 12, 2026
Next Post
Lucid Motors (LCID) updates its 2024 model year Airs, including lower prices and a RWD Pure

Lucid Motors (LCID) updates its 2024 model year Airs, including lower prices and a RWD Pure

Related News

Solana community votes to give validators all priority fees

Solana community votes to give validators all priority fees

May 27, 2024
Icahn Enterprises CEO to become head of Pep Boys

Icahn Enterprises CEO to become head of Pep Boys

February 21, 2024
Ride1Up Roadster V3 review: Now THIS is how you build an electric bike!

Ride1Up Roadster V3 review: Now THIS is how you build an electric bike!

October 28, 2024

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?